Literature DB >> 24871783

Surgical management of locally advanced lung cancer.

Kohei Yokoi1, Tetsuo Taniguchi, Noriyasu Usami, Koji Kawaguchi, Takayuki Fukui, Futoshi Ishiguro.   

Abstract

Majority of cases of lung cancer are detected at an advanced stage; such patients are usually treated with chemotherapy and radiotherapy, and the prognosis is frequently poor. Surgical resection remains the only reliable curative method for the treatment of lung cancer, and combined resection of the primary tumor and involved neighboring structures is performed when possible in patients with locally advanced disease. In the TNM classification, tumors with direct extrapulmonary extension are subdivided based on the anatomic extent of disease and its potential for surgical treatment: T3 lesions with limited, circumscribed extension are thought to be potentially surgically resectable, whereas T4 tumors with extensive extension are considered unresectable. Although surgical treatment for T3 lesions is generally accepted, the outcome is frequently not satisfactory. On the other hand, advanced surgical techniques are now being applied for T4 lesions due to improvements in surgery and anesthesiology and progress in combined treatment modalities. In the present staging, T4N0-1M0 lesions are categorized as stage IIIA disease, and T4 tumors without mediastinal nodal metastasis are now considered to be potentially curable if complete resection is possible. This article reviews the modern surgical management of patients with lung cancer invading neighboring structures, including the chest wall, superior sulcus, diaphragm, tracheal carina, left atrium, superior vena cava, aorta and vertebrae. Furthermore, the surgical treatment of carcinomatous pleuritis, which was categorized as T4 disease in the previous TNM classification, is also assessed, and the role of surgical resection in cases of locally advanced lung cancer is discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24871783     DOI: 10.1007/s11748-014-0425-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  69 in total

1.  Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.

Authors:  J D Mitchell; D J Mathisen; C D Wright; J C Wain; D M Donahue; J S Allan; A C Moncure; H C Grillo
Journal:  J Thorac Cardiovasc Surg       Date:  2001-03       Impact factor: 5.209

2.  Long-term results after carinal resection for carcinoma: does the benefit warrant the risk?

Authors:  Marc de Perrot; Elie Fadel; Olaf Mercier; Sacha Mussot; Alain Chapelier; Philippe Dartevelle
Journal:  J Thorac Cardiovasc Surg       Date:  2005-12-05       Impact factor: 5.209

3.  Surgical management of lung cancer invading the aorta or the superior vena cava.

Authors:  P Misthos; G Papagiannakis; J Kokotsakis; G Lazopoulos; E Skouteli; A Lioulias
Journal:  Lung Cancer       Date:  2007-01-16       Impact factor: 5.705

4.  Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies.

Authors:  Christophe Doddoli; Benoit D'Journo; Françoise Le Pimpec-Barthes; Antoine Dujon; Christophe Foucault; Pascal Thomas; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

5.  Clinical experience with carinal resection.

Authors:  J D Mitchell; D J Mathisen; C D Wright; J C Wain; D M Donahue; A C Moncure; H C Grillo
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

6.  A fenestrated stent graft for surgical resection of lung cancer invading the aortic arch.

Authors:  Toshiyuki Nagata; Yoshihiro Nakamura; Hiroyuki Yamamoto; Masami Sato
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-26       Impact factor: 5.209

7.  Results of surgical treatment of lung cancer involving the diaphragm.

Authors:  K Yokoi; R Tsuchiya; T Mori; K Nagai; T Furukawa; S Fujimura; K Nakagawa; Y Ichinose
Journal:  J Thorac Cardiovasc Surg       Date:  2000-10       Impact factor: 5.209

8.  En bloc resection of non-small-cell lung cancer invading the spine.

Authors:  Joachim Schirren; Tina Dönges; Michael Melzer; Robert Schönmayr; Michael Eberlein; Servet Bölükbas
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-21       Impact factor: 4.191

9.  Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine.

Authors:  Masaki Anraku; Thomas K Waddell; Marc de Perrot; Stephen J Lewis; Andrew F Pierre; Gail E Darling; Michael R Johnston; Rebecca E Zener; Yoga R Rampersaud; Frances A Shepherd; Natasha Leighl; Andrea Bezjak; Alexander Y Sun; David M Hwang; Ming-Sound Tsao; Shaf Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2008-12-19       Impact factor: 5.209

Review 10.  Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.

Authors:  Giovanni B Ratto; Roberta Costa; Giuseppe Vassallo; Antonella Alloisio; Paola Maineri; Paolo Bruzzi
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

View more
  8 in total

1.  Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach.

Authors:  Mauro Loi; Antonio Mazzella; Isacco Desideri; Ludovic Fournel; Emelyne Canny Hamelin; Philippe Icard; Antonio Bobbio; Marco Alifano
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

2.  Collaborative operation with cardiovascular surgeons in general thoracic surgery.

Authors:  Koichi Fukumoto; Koji Kawaguchi; Takayuki Fukui; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Taketo Kato; Hideki Oshima; Akihiko Usui; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-07-07

3.  Clinic application of tissue engineered bronchus for lung cancer treatment.

Authors:  Qiang Tan; Ruijun Liu; Xiaoke Chen; Jingxiang Wu; Yinggen Pan; Shun Lu; Walter Weder; Qingquan Luo
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

4.  Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.

Authors:  Honggang Zhao; Yan Jiao; Zuncheng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

5.  Construction of subtype-specific prognostic gene signatures for early-stage non-small cell lung cancer using meta feature selection methods.

Authors:  Chunshui Liu; Linlin Wang; Tianjiao Wang; Suyan Tian
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

6.  Clinical application of a surgical navigation system based on virtual thoracoscopy for lung cancer patients: real time visualization of area of lung cancer before induction therapy and optimal resection line for obtaining a safe surgical margin during surgery.

Authors:  Shota Nakamura; Yuichiro Hayashi; Koji Kawaguchi; Takayuki Fukui; Shuhei Hakiri; Naoki Ozeki; Shunsuke Mori; Masaki Goto; Kensaku Mori; Kohei Yokoi
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

7.  Which variables should be considered in patients with stage II and III non-small cell lung cancer after neoadjuvant therapy?

Authors:  Naoki Ozeki; Koji Kawaguchi; Takayuki Fukui; Koichi Fukumoto; Shota Nakamura; Toshiki Okasaka; Kohei Yokoi
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

8.  Long-term survival in locally advanced non-small cell lung cancer invading the great vessels and heart.

Authors:  Byungjoon Park; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Jae Il Zo; Young Mog Shim; Jhingook Kim
Journal:  Thorac Cancer       Date:  2018-03-30       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.